Cencora Price to Sales Ratio 2010-2023 | COR
Historical PS ratio values for Cencora (COR) over the last 10 years. The current P/S ratio for Cencora as of April 25, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cencora P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-04-25 | 239.76 | 0.18 | |
| 2023-12-31 | 204.93 | $1,333.10 | 0.15 |
| 2023-09-30 | 179.11 | $1,279.72 | 0.14 |
| 2023-06-30 | 191.02 | $1,232.48 | 0.15 |
| 2023-03-31 | 158.48 | $1,188.58 | 0.13 |
| 2022-12-31 | 163.52 | $1,150.18 | 0.14 |
| 2022-09-30 | 133.12 | $1,127.96 | 0.12 |
| 2022-06-30 | 138.75 | $1,120.92 | 0.12 |
| 2022-03-31 | 151.27 | $1,092.89 | 0.14 |
| 2021-12-31 | 129.51 | $1,057.71 | 0.12 |
| 2021-09-30 | 115.98 | $1,029.28 | 0.11 |
| 2021-06-30 | 110.76 | $987.16 | 0.11 |
| 2021-03-31 | 113.79 | $952.23 | 0.12 |
| 2020-12-31 | 93.82 | $944.14 | 0.10 |
| 2020-09-30 | 92.64 | $920.85 | 0.10 |
| 2020-06-30 | 95.93 | $895.81 | 0.11 |
| 2020-03-31 | 83.84 | $889.33 | 0.09 |
| 2019-12-31 | 80.19 | $864.13 | 0.09 |
| 2019-09-30 | 77.30 | $845.62 | 0.09 |
| 2019-06-30 | 79.68 | $826.69 | 0.10 |
| 2019-03-31 | 73.94 | $807.87 | 0.09 |
| 2018-12-31 | 68.86 | $788.66 | 0.09 |
| 2018-09-30 | 84.97 | $759.77 | 0.11 |
| 2018-06-30 | 78.23 | $739.80 | 0.11 |
| 2018-03-31 | 78.74 | $718.83 | 0.11 |
| 2017-12-31 | 83.54 | $702.16 | 0.12 |
| 2017-09-30 | 74.93 | $690.86 | 0.11 |
| 2017-06-30 | 85.20 | $680.55 | 0.13 |
| 2017-03-31 | 79.44 | $670.16 | 0.12 |
| 2016-12-31 | 69.90 | $660.58 | 0.11 |
| 2016-09-30 | 71.89 | $650.55 | 0.11 |
| 2016-06-30 | 70.32 | $647.19 | 0.11 |
| 2016-03-31 | 76.38 | $625.63 | 0.12 |
| 2015-12-31 | 91.17 | $615.62 | 0.15 |
| 2015-09-30 | 83.21 | $606.75 | 0.14 |
| 2015-06-30 | 92.89 | $578.08 | 0.16 |
| 2015-03-31 | 99.05 | $570.02 | 0.17 |
| 2014-12-31 | 78.33 | $542.13 | 0.14 |
| 2014-09-30 | 66.94 | $512.17 | 0.13 |
| 2014-06-30 | 62.73 | $481.96 | 0.13 |
| 2014-03-31 | 56.43 | $440.47 | 0.13 |
| 2013-12-31 | 60.28 | $407.52 | 0.15 |
| 2013-09-30 | 52.21 | $373.65 | 0.14 |
| 2013-06-30 | 47.36 | $342.60 | 0.14 |
| 2013-03-31 | 43.47 | $325.23 | 0.13 |
| 2012-12-31 | 36.32 | $312.86 | 0.12 |
| 2012-09-30 | 32.39 | $300.82 | 0.11 |
| 2012-06-30 | 32.82 | $295.91 | 0.11 |
| 2012-03-31 | 32.96 | $292.59 | 0.11 |
| 2011-12-31 | 30.79 | $288.10 | 0.11 |
| 2011-09-30 | 30.75 | $281.75 | 0.11 |
| 2011-06-30 | 34.06 | $281.76 | 0.12 |
| 2011-03-31 | 32.46 | $277.88 | 0.12 |
| 2010-12-31 | 27.92 | $274.46 | 0.10 |
| 2010-09-30 | 25.00 | $269.98 | 0.09 |
| 2010-06-30 | 25.82 | $263.79 | 0.10 |
| 2010-03-31 | 23.46 | $256.60 | 0.09 |
| 2009-12-31 | 21.09 | $246.23 | 0.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $47.467B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.048B | 15.56 |
| ICON (ICLR) | Ireland | $25.527B | 24.10 |
| DiDi Global (DIDIY) | China | $23.901B | 0.00 |
| Avantor (AVTR) | United States | $17.269B | 23.79 |
| Viatris (VTRS) | United States | $13.856B | 3.96 |
| CochLear (CHEOY) | $13.551B | 0.00 | |
| Revvity (RVTY) | United States | $12.684B | 22.08 |
| Charles River Laboratories (CRL) | United States | $12.333B | 22.48 |
| Medpace Holdings (MEDP) | United States | $12.318B | 40.53 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.750B | 0.00 |
| Natera (NTRA) | United States | $11.049B | 0.00 |
| Solventum (SOLV) | United States | $10.961B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.795B | 50.77 |
| Bausch + Lomb (BLCO) | Canada | $5.236B | 20.14 |
| Organon (OGN) | United States | $4.783B | 4.63 |
| Doximity (DOCS) | United States | $4.461B | 33.21 |
| PACS (PACS) | United States | $3.596B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.228B | 30.00 |
| Sotera Health (SHC) | United States | $3.190B | 15.65 |
| Progyny (PGNY) | United States | $3.133B | 52.58 |
| Life Times (LTH) | United States | $2.882B | 31.85 |
| GoodRx Holdings (GDRX) | United States | $2.749B | 139.20 |
| Premier (PINC) | United States | $2.531B | 9.26 |
| Teladoc Health (TDOC) | United States | $2.325B | 0.00 |
| Agilon Health (AGL) | United States | $2.191B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.167B | 7.01 |
| BrightSpring Health Services (BTSG) | United States | $1.845B | 0.00 |
| Agiliti (AGTI) | United States | $1.374B | 22.44 |
| Establishment Labs Holdings (ESTA) | $1.344B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.328B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.979B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.776B | 8.03 |
| Embecta (EMBC) | United States | $0.627B | 4.14 |
| Auna S.A (AUNA) | Luxembourg | $0.558B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.542B | 0.00 |
| Enhabit (EHAB) | United States | $0.510B | 46.23 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.502B | 0.00 |
| LifeMD (LFMD) | United States | $0.450B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.423B | 0.00 |
| CareDx (CDNA) | United States | $0.413B | 0.00 |
| Beauty Health (SKIN) | United States | $0.389B | 0.00 |
| MultiPlan (MPLN) | United States | $0.375B | 0.00 |
| DocGo (DCGO) | United States | $0.367B | 58.67 |
| ModivCare (MODV) | United States | $0.353B | 4.68 |
| Sera Prognostics (SERA) | United States | $0.326B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.308B | 0.00 |
| Sharecare (SHCR) | United States | $0.277B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.265B | 0.00 |
| Biodesix (BDSX) | United States | $0.145B | 0.00 |
| So-Young (SY) | China | $0.121B | 40.67 |
| Oncology Institute (TOI) | United States | $0.089B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.077B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.028B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.020B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.014B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |